What Aceclofenac/Paracetamol Treats: Main Uses and Benefits

This combination is relevant for easing symptoms related to inflammatory or irritative states in conditions presenting with systemic or localized discomfort, particularly in the musculoskeletal domain. It is commonly used for chronic conditions like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis, as well as acute issues such as lumbago, sprains, and strains.

Symptom Management and Supportive Relief

The medication is applied across domains where additional symptomatic support is needed and may assist with maintaining functional stability. It is relevant for managing symptom clusters that may become intense or disruptive, such as severe dental pain or inflammatory conditions like periarthritis. Furthermore, the combination may be part of symptomatic management applied in contexts involving symptoms related to systemic imbalance, particularly fever, when it is associated with painful or inflammatory states. This supportive relief may help patients cope more steadily when symptoms interfere with routine activities, including the management of episodic pain like dysmenorrhea.

Quick Fact
Symptomatic Domains	Pain, Inflammation, and Fever

Official Regulatory Eligibility Status

The Aceclofenac/Paracetamol combination is approved for use in adults (18 years and older) who do not have any listed contraindications. Official labeling specifies populations that must not use this medicine.

It is strictly contraindicated for individuals with known hypersensitivity to Aceclofenac, Paracetamol, or other NSAIDs, and for those with active or recurrent peptic ulcer/haemorrhage or a history of GI bleeding related to previous NSAID therapy. Use is also prohibited in patients with severe heart failure, severe hepatic failure, or severe renal failure, as well as in those with established cardiovascular or cerebrovascular disease. The medicine is contraindicated during the last trimester of pregnancy.

Use is not recommended in children under 18 years of age due to insufficient clinical data. Geriatric patients must use the lowest effective dose under careful surveillance due to increased risk of GI adverse events. Furthermore, the medicine is not recommended for women who are breastfeeding or attempting to conceive. Patients with mild-to-moderate organ impairment or a history of inflammatory bowel disease require special caution and close medical surveillance.

Interactions with other medicines and products

The official regulatory profile for Aceclofenac/Paracetamol details interaction patterns governed by its two active ingredients, Aceclofenac (an NSAID) and Paracetamol (Acetaminophen). All interaction information is strictly based on government regulatory documentation, defining specific co-administration restrictions and outcomes.

Contraindicated Combinations

Co-administration with other NSAIDs, including COX-2 selective inhibitors, is explicitly restricted due to the increased risk of severe adverse events, such as gastrointestinal bleeding. Combination with any other product containing Paracetamol is prohibited because it significantly increases the risk of dose-related liver toxicity.

---

Pharmacodynamic and Exposure Interactions

Interacting Substance Class	Documented Interaction Outcome
Oral Anticoagulants (e.g., Warfarin)	Increased risk of bleeding due to enhanced anticoagulant effect.
ACE Inhibitors/ARBs and Diuretics	Reduction of the antihypertensive or diuretic effect.
Lithium or Digoxin	Increased plasma concentrations of these substances due to inhibited renal clearance.
Ciclosporin or Tacrolimus	Increased risk of nephrotoxicity.
Enzyme Inducers (e.g., certain Antiepileptics)	Increased risk of Paracetamol hepatotoxicity due to accelerated formation of toxic metabolites.

---

Timing and Substance Restrictions

Regular, chronic consumption of alcohol is documented to increase the risk of liver damage from the Paracetamol component. For substances like Colestyramine, which reduce the absorption speed of Paracetamol, regulatory labeling advises a timing separation of at least one hour if maximal analgesic effect is required. Increased interaction severity is noted for elderly patients and those with hepatic or renal impairment.

Aceclofenac and paracetamol are two distinct agents that modulate biological processes through separate mechanistic domains.

Modulation of Peripheral Prostaglandin Synthesis

This domain covers the action of Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID). It acts primarily by inhibiting the cyclo-oxygenase (COX) enzyme system, particularly the COX-2 isoform, which is responsible for the synthesis of lipid mediators called prostaglandins (like PGE2). By suppressing prostaglandin production at the site of tissue stress, the molecule reduces the local concentration of inflammatory mediators, resulting in the modification of peripheral physiological signaling patterns.

---

Central Modulation of Nociceptive Pathways

This domain involves the action of Paracetamol. Its primary mechanism is focused centrally, where it modulates prostaglandin synthesis in the brain and spinal cord, an effect that may be mediated by an active metabolite, AM404, influencing specific central COX activity. This action initiates or suppresses signaling sequences within the central nervous system, particularly affecting the hypothalamic heat-regulating center and descending serotonergic pathways, contributing to the functional alteration of central thermal and nociceptive signaling.

How to Use Aceclofenac/Paracetamol

This section describes the administration and dosing patterns for the Aceclofenac/Paracetamol fixed-dose combination (FDC) tablet. Usage is defined by the principle of administering the lowest effective dose for the shortest duration necessary to control symptoms.

---

General Administration

The route of administration for this FDC is oral. The tablet is swallowed whole with a sufficient quantity of liquid, and it is generally taken preferably with or after food. Taking the tablet with food affects only the rate, but not the overall extent, of Aceclofenac absorption.

---

Dosing and Schedule

Instruction	Guideline
Standard Dosing (Adults)	One FDC tablet taken twice daily.
Daily Maximum	The total daily dose of the Aceclofenac component is 200 mg, taken as two divided doses.
Duration Principle	Treatment duration is typically limited to the shortest period required for symptom control. For prolonged use, regular monitoring is performed.

---

Adjustments for Specific Populations

Information regarding certain populations includes:

• Hepatic Impairment: For patients with mild hepatic impairment, an initial daily dose of the Aceclofenac component of 100 mg is described.
• Older Adults: While specific dose modifications may not be required for the Aceclofenac component, the lowest effective dose for the shortest duration is utilized due to a generally higher risk profile in this population.

The recommended maximum dose is not to be exceeded as outlined in the prescribing instructions.

Research evidence / Overview of studies for Aceclofenac/paracetamol

Evidence for Chronic Musculoskeletal Conditions

Research that examined conditions characterized by fluctuating or episodic manifestations, such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis (AS), has primarily explored the Aceclofenac component when taken alone. These studies involved adults and frequently used Randomized Controlled Trials (RCTs) to examine the Aceclofenac component and compare it to other nonsteroidal anti-inflammatory drugs (NSAIDs) or paracetamol monotherapy. Research monitored outcomes related to physical discomfort and outcomes reflecting daily functioning, such as specific functional indices (e.g., WOMAC scores), used in observational settings evaluating daily-life functioning.

The evidence base describes patterns observed in these studies, which measured changes in symptoms in the observed populations over defined time intervals. The coarse evidence grading for the Aceclofenac component in these conditions is categorized as Moderate.

Evidence for Acute Pain and Painful Flare-ups

Studies were conducted during periods of increased symptom activity, focusing on conditions associated with acute or disruptive episodes, such as painful flare-ups of OA and acute low back pain. This research included Randomized Comparative Trials designed to study the FDC and compare it to monotherapy approaches, such as Aceclofenac or paracetamol taken alone. Systematic reviews describe patterns indicating that outcomes related to physical discomfort for the combination approach were observed to be different from those reported for monotherapy in certain studies.

The observation periods for these studies were generally immediate to short-term; data are primarily restricted to outcomes measured within 10 days to two weeks. The overall certainty level of the evidence for the FDC versus monotherapy remains low-to-moderate, based on the assessment of systematic reviews. Results apply only to the populations studied.

Unanswered Questions and Research Gaps

Key research limitation frames include the fact that the Fixed-Dose Combination lacks direct, long-term comparative evidence for chronic management. Additionally, follow-up durations were limited across most trials, meaning long-term outcomes are not fully established. For specific subgroups, such as very older adults or patients with various underlying comorbid conditions, subgroup findings are uncertain or data are still emerging.

Key Studies & References

1. Synergistic effects of non-steroidal anti-inflammatory drugs and acetaminophen (paracetamol) for acute pain relief: a systematic review of the literature
2. MedlinePlus Drug Information: Acetaminophen

Common questions about Aceclofenac/paracetamol (FAQ)

---

Q: How does Aceclofenac/paracetamol compare to just taking regular paracetamol?

The key difference is the inclusion of Aceclofenac, which is a non-steroidal anti-inflammatory drug (NSAID). Official information indicates that Paracetamol primarily relieves pain and fever through central effects, while Aceclofenac works mainly to reduce inflammation in the body. The combination is designed to provide relief for both pain and underlying inflammation simultaneously.

---

Q: Is it necessary to take Aceclofenac/paracetamol with food?

Regulatory documents advise that this medicine should be taken preferably with or immediately after food. This advice is generally included in patient information and is related to how the body tolerates the medication. Taking the tablet with food affects the rate at which Aceclofenac is absorbed, but it does not change the total amount of the drug that enters the body.

---

Q: Is Aceclofenac/paracetamol safe for long-term use?

Official safety guidelines describe the use of the medicine as being for the shortest possible duration at the lowest effective dose. For extended or prolonged use, official documentation requires the patient to undergo regular monitoring. The official guidance also notes that the risk of cardiovascular events may increase with longer treatment duration and higher doses.

---

Q: Does Aceclofenac/paracetamol affect blood pressure?

Official prescribing information lists Hypertension (high blood pressure) and Cardiac failure as rare adverse reactions. Furthermore, caution is advised for patients who have pre-existing cardiovascular conditions, which includes high blood pressure.

---

Q: Can people with liver problems use Aceclofenac/paracetamol?

Use of this medicine is strictly contraindicated (prohibited) in patients with severe liver failure. For individuals with mild liver impairment, official documents suggest dose modifications for the Aceclofenac component. Use is generally prohibited in severe liver failure. Caution is advised overall due to the risk of liver damage from the Paracetamol component.

---

Q: Is Aceclofenac/paracetamol suitable for elderly patients?

Official guidelines describe that older adults are documented as being at a significantly increased risk of serious adverse reactions, especially those affecting the gastrointestinal tract. Therefore, official prescribing information calls for the use of the lowest effective dose for the shortest duration under careful surveillance.

---

Q: Why do official documents mention cautions about Aceclofenac/paracetamol and driving?

Official documents include warnings that this medicine may cause central nervous system side effects such as dizziness, visual disturbance, or drowsiness. Regulatory warnings state that individuals experiencing these symptoms are generally restricted from driving or operating machinery.

---

Q: Is skin rash a common or serious side effect of Aceclofenac/paracetamol?

Skin reactions like rash, itching, and dermatitis are listed as uncommon side effects (affecting fewer than 1 in 100 people). However, regulatory documents also detail rare but extremely serious skin conditions, such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

---

Q: Does Aceclofenac/paracetamol interact with herbal supplements?

Official drug information details known interactions with prescription medicines and specific non-drug substances like alcohol. A comprehensive safety evaluation is generally not available for the vast number of herbal remedies and supplements. Official patient information often directs individuals to report all concurrent use of supplements to their healthcare professional for evaluation.

---

Q: How quickly should I expect Aceclofenac/paracetamol to start working?

Regulatory documents indicate that the onset of action can be within approximately 30 minutes of ingestion. The concentration of the medicine in the blood reaches its peak level between 1 and 3 hours, according to pharmacokinetic data.

---

Q: What is the typical duration of pain relief from one dose of Aceclofenac/paracetamol?

Official pharmacokinetic data indicates that the average elimination half-life is approximately 4 hours for the Aceclofenac component and between 1 and 4 hours for Paracetamol. The duration of the therapeutic effect is closely linked to these elimination rates.

---

Q: Is it normal to feel drowsy after using Aceclofenac/paracetamol?

Official drug safety information lists dizziness as a common side effect. Some regulatory documents also specifically list drowsiness as a possible, though less common, effect. Any central nervous system effect can vary among individuals.

---

Q: What other common medicines might interact with Aceclofenac/paracetamol?

Official documents list potential interactions with several medication classes. These include blood thinners like warfarin, medicines for high blood pressure such as ACE inhibitors, diuretics (water pills), and certain medicines used to treat conditions like bipolar disorder or epilepsy.

---

Q: If I miss a dose of Aceclofenac/paracetamol, what should I generally do?

Official patient instructions describe the general protocol for a missed dose. This usually involves taking the dose when remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose is omitted. Regulatory cautions prohibit taking two doses at once to compensate for a forgotten dose.

---

Q: Can Aceclofenac/paracetamol affect fertility?

Official regulatory documents state that the use of the Aceclofenac component may impair female fertility because of its mechanism of action. For this reason, use is not recommended in women who are attempting to conceive. Discontinuation of the medicine should be considered for women undergoing investigation for infertility.

---

Q: What happens if I accidentally take more than the typical dose of Aceclofenac/paracetamol?

Official warnings state that taking multiple daily doses at once can cause severe liver damage from the Paracetamol component. This damage may not present with immediate symptoms. Official warnings state that immediate medical attention is required following an overdose, regardless of whether a person feels ill, due to the risk of irreversible liver damage.

---

Q: What is the difference between Aceclofenac and Diclofenac?

Aceclofenac is described in regulatory documents as a chemical derivative of Diclofenac, and both belong to the Non-Steroidal Anti-inflammatory Drug (NSAID) class. Both function by reducing inflammatory mediators called prostaglandins. Some research documented in official materials has examined differences in how the two substances are tolerated, particularly regarding gastrointestinal side effects.

---

Q: Does the drug come in different strengths?

Yes, regulatory product labeling confirms that this fixed-dose combination (FDC) is often available in different strength ratios, depending on the manufacturer and the market. Examples of officially registered strengths include Aceclofenac 100 mg combined with Paracetamol 500 mg, as well as other combinations.

---

Q: Can this medication affect sleep?

The official list of side effects includes central nervous system effects such as dizziness and drowsiness as possible effects. While general sleep disruption is not commonly listed, the presence of these CNS-related side effects may indirectly influence a person's ability to rest.

---

Q: Does Aceclofenac/paracetamol have a known potential for abuse?

The combination contains an NSAID and Paracetamol, neither of which are classified as narcotic or controlled substances under official regulatory schedules. The medicine is not typically discussed in official documents in terms of potential for abuse, as is standard for non-opioid medications.

---

Q: Does taking Aceclofenac/paracetamol affect laboratory blood tests?

Official documentation indicates that individuals receiving long-term treatment should be regularly monitored with liver function tests, renal function tests, and blood counts. Additionally, regulatory warnings note that Paracetamol may officially interfere with the results of certain laboratory tests, such as those for blood sugar or uric acid.

Storage and Disposal Requirements for Aceclofenac/Paracetamol Tablets

Aceclofenac/Paracetamol tablets must be stored under specific conditions to maintain their stability and efficacy, as required by regulatory labeling.

Storage Conditions

• Temperature and Protection: The product must be stored at a temperature below 30 C and protected from both light and moisture.
• Container: The medicine should be kept in its original container and maintained in a dry, well-ventilated location.
• Child Safety: It is mandatory to keep the tablets out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Aceclofenac/Paracetamol must be discarded according to local regulations. In many regions, the medicine must not be disposed of via household waste or flushed down the toilet; instead, it should be taken to an approved pharmaceutical waste disposal program.